Evidence map›Paper›PMID 36290871›Full record

ArticleCurrent oncology (Toronto, Ont.)2022

Repurposed Effect of

Mohamad K Elajami, Lorena P Burton, Hisham F Bahmad, Gerard Chaaya, Michael Schwartz

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Current oncology (Toronto, Ont.), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. LutatheraPharmaceutics · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Mohamad K ElajamiDepartment of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Lorena P BurtonDepartment of Internal Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Hisham F BahmadArkadi M. Rywlin M.D. Department of Pathology and Laboratory Medicine, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Gerard ChaayaDepartment of Internal Medicine, Division of Hematology and Oncology, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.ORCID 0000-0001-7798-9409
Michael SchwartzDepartment of Internal Medicine, Division of Hematology and Oncology, Mount Sinai Medical Center, Miami Beach, FL 33140, USA.
Mount Sinai Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mantle cell lymphoma (MCL) is an uncommon subcategory of non-Hodgkin lymphoma (NHL). Pathogenesis primarily includes overexpression of

Indexed as

Carcinoid TumorLymphoma, Mantle-CellAdultAged, 80 and overHumansLutetiumMaleRadiopharmaceuticalsSomatostatinLutetiumRadiopharmaceuticalsSomatostatincarcinoidcase reportDOTATATEdrug repurposingmantle cell lymphoma

Identifiers

PMID36290871
PMCPMC9599960
OpenAlexW4303946548

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.